Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1-10 of 30

Page
per page
  1. PR-619
    A8212 PR-619
    Target: Deubiquitinating enzymes (DUBs)
    Summary: Deubiquitylating enzymes (DBUs) inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.15 mg/mL
  2. Lapatinib
    A8218 Lapatinib
     2 Citation
    Target: ErbB
    Summary: EGFR/HER2 inhibitor,potent,selective and reversible
      ≥29.05 mg/mL
  3. PP 1
    A8215 PP 1
    Target: Src|EGFR|JAK|ZAP-70
    Summary: Src family tyrosine kinase inhibitor
  4. LY 294002
    A8250 LY 294002
     16 Citation
    Target: PI3K
    Summary: Potent PI3K inhibitor
  5. SP 600125
    A4604 SP 600125
     7 Citation
    Target: JNK
    Summary: JNK1/2/3 inhibitor
      insoluble in H2O; ≥11 mg/mL
  6. Ki16425
    A1987 Ki16425
     4 Citation
    Target: LPA Receptors
    Summary: LPA receptor antagonist
      ≥23.75 mg/mL
  7. AZD7762
    A5919 AZD7762
    Target: Chk
    Summary: Checkpoint kinase inhibitor,ATP competitive
      insoluble in H2O; insoluble in EtOH; ≥18.1 mg/mL
  8. PF-562271
    A8310 PF-562271
     1 Citation
    Target: FAK|Pyk2
    Summary: ATP-competitive FAK inhibitor, reversible
      ≥25.35 mg/mL
  9. PF-00562271
    A8320 PF-00562271
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor,potent and ATP-competitive
      insoluble in EtOH; insoluble in H2O; ≥11.1 mg/mL
  10. KU-60019
    A8336 KU-60019
     2 Citation
    Target: ATM/ATR
    Summary: ATM kinase inhibitor,potent and selective
      ≥27.4 mg/mL

Items 1-10 of 30

Page
per page